Lamb, Lawrence S <br/><br/>
Clinical-scale manufacturing of γδ T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis.  [electronic resource] 

 -  Bone marrow transplantation  06 2018 
 - 766-769 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/s41409-018-0130-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cyclophosphamide--adverse effects<br/>Female<br/>Graft vs Host Disease--prevention & control<br/>Humans<br/>Male<br/>Neoplasm Recurrence, Local<br/>Peripheral Blood Stem Cell Transplantation--adverse effects<br/>T-Lymphocytes--metabolism<br/>Transplantation, Haploidentical--adverse effects